Connection

KEITH WEBSTER to Diabetic Retinopathy

This is a "connection" page, showing publications KEITH WEBSTER has written about Diabetic Retinopathy.
Connection Strength

0.664
  1. Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy. Int J Mol Sci. 2024 Sep 01; 25(17).
    View in: PubMed
    Score: 0.199
  2. Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy. Int J Mol Sci. 2023 Jun 23; 24(13).
    View in: PubMed
    Score: 0.183
  3. Neurovascular regulation in diabetic retinopathy and emerging therapies. Cell Mol Life Sci. 2021 Aug; 78(16):5977-5985.
    View in: PubMed
    Score: 0.160
  4. Secretogranin III: a diabetic retinopathy-selective angiogenic factor. Cell Mol Life Sci. 2018 02; 75(4):635-647.
    View in: PubMed
    Score: 0.122
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.